TABLE 2

Changes in screened analytes over the 4-week study period

Control group
Treatment group
P
Initial valueChange in value at 4 weeksInitial valueChange in value at 4 weeks
n12121414
Leptin (ng/ml)283 ± 2431 ± 25325 ± 50−79 ± 350.0185*
Adiponectin (μg/ml)111.4 ± 11.3−7.6 ± 3.083.6 ± 9.58.3 ± 4.30.0068*
Insulin (pmol/l)26.7 ± 8.5−1.1 ± 5.434.5 ± 4.7−7.8 ± 4.40.3394
Glucose (mmol/l)4.61 ± 0.090.21 ± 0.094.76 ± 0.110.12 ± 0.080.4111
Cholesterol (mmol/l)4.71 ± 0.26−0.26 ± 0.154.66 ± 0.19−0.15 ± 0.110.5154
HDL (mmol/l)1.07 ± 0.06−0.01 ± 0.031.12 ± 0.09−0.02 ± 0.030.8459
Ghrelin (pmol/l493 ± 8747 ± 58371 ± 6535 ± 440.8586
Peptide YY (pmol/l)11.8 ± 1.6−2.6 ± 1.512.2 ± 2.1−0.6 ± 1.60.3651
  • Data are means ± SE. An unpaired t test was used to compare changes in the control vs. the treatment group.

  • *

    * Significant difference.